About us
Research Library
Company Pages
Allergy Therapeutics
ANGLE
Arecor Therapeutics
Avacta
Futura Medical
HUTCHMED
Redx Pharma
Scancell
Contact us
More Company News
Scancell
Positive data from first stage of SCIB1 Phase II SCOPE trial in advanced melanoma
19 Sep 2023
Read More
Scancell
Appointment of Head of Business Development
07 Sep 2023
Read More
Scancell
Appointment of CFO
29 Aug 2023
Read More
Scancell
Modi-1 trial open for expansion in CPI combination
31 Jul 2023
Read More
Scancell
Pipeline strategy and business update
10 Jul 2023
Read More
Scancell
ModiFY Phase I/II data at ASCO 2023
02 Jun 2023
Read More
Scancell
ModiFY Phase 1/2 poster at AACR 2023
18 Apr 2023
Read More
Scancell
Encouraging early efficacy data from ModiFY trial
21 Feb 2023
Read More
Scancell
Positive response in COVIDITY trial
13 Feb 2023
Read More
Scancell
Dr Jean-Michel Cosséry appointed Chairman
01 Feb 2023
Read More
1
2
3
4
…
9
Return to Scancell
© 2019-22 Trinity Delta. All rights reserved. Trinity Delta is regulated by the Financial Conduct Authority (Reference number: 725161).
About us
Research Library
Company Pages
â–¼
Allergy Therapeutics
ANGLE
Arecor Therapeutics
Avacta
Futura Medical
HUTCHMED
Redx Pharma
Scancell
Contact us